The largest database of trusted experimental protocols

Taqman mirna reverse transcription kit

Manufactured by Takara Bio
Sourced in Japan, China

The TaqMan miRNA Reverse Transcription Kit is a laboratory product designed for the reverse transcription of mature microRNA (miRNA) molecules. It provides a standardized method for the conversion of miRNA into complementary DNA (cDNA) for subsequent quantitative PCR analysis. The kit includes all the necessary reagents and protocols to perform this specific process.

Automatically generated - may contain errors

10 protocols using taqman mirna reverse transcription kit

1

Quantitative Analysis of miRNA and mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from cultured cells and surgically resected fresh-frozen CRC tissue using the miRNeasy kit (QIAGEN) according to the manufacturer's instructions. RNA quality was examined by A260/A280 absorption. The complementary DNA (cDNA) to be used for detecting miRNAs was synthesized with a TaqMan miRNA reverse transcription kit (Takara). For mRNA detection, 500 ng of total RNA was used for cDNA synthesis in a 10-µl system with a PrimeScriptTM RT Master Mix kit (Takara). qPCR was performed in triplicate using SYBR® Premix Ex TaqTM II (Takara) with the CFX96™ QPCR Detection System (Bio-Rad). The primers specific to mature miR-302a were purchased from RiboBio (Guangzhou, China). The primers for the other genes of interest were synthesized by Takara. U6 and GAPDH were used as internal controls. The 2-ΔΔCT method was used to determine the fold changes in the mRNA levels between each sample and the reference sample. Primer information is listed in Table S4.
+ Open protocol
+ Expand
2

Quantification of miRNAs and c-myc mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from prostate tissue or LNCaP cells using Trizol (Takara, Japan). For miRNAs qRT-PCR, a total of 10 ng of RNA was transcribed into cDNA using the Taqman miRNA reverse transcription kit (Takara, Japan). And real-time PCR was performed with specific sense primers (Supplementary Table S1) and general antisense primer supplied by miRNA PrimeScript RT Enzyme Mix Kit (Takara, Japan) according to the manufacturer’s instructions. Quantitative c-myc gene-expression analysis was performed with specific primers (Supplementary Table S2) by using one step SYBR PrimeScript plus RT-PCR kit (Takara, Japan) according to the manufacturer’s instructions. MiRNAs and mRNA expression were normalized to RNU6 and GAPDH, respectively, using the 2−∆∆Ct method.
+ Open protocol
+ Expand
3

Quantification of Prostate Cancer Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated using the total RNA kit (Omega Bio-tek, Inc., Guangzhou, China) and reversely transcribed to cDNAs with a TaqMan miRNA Reverse Transcription Kit (TaKaRa, Dalian, Liaoning, China). The mRNA levels of Siah2, NKX3.1, PSA, PMEPA1, and SLC45A3were quantified by real-time quantitative PCR performed with SYBR Premix Ex Taq II (TaKaRa; Dalian, Liaoning, China). PCR was carried out with a two-step qRT-PCR with specific primers for GAPDH (as internal control) at 95 °C for 30s, followed by 40 cycles of amplification at95°C for 5 s and 56 °C for 30s. All results were representative of three independent assays, and the levels of mRNAs were expressed as 2-ΔΔCT. The designed specific primers were listed in Table 1.

Sequences for target gene primer for RT-PCR

GenePrimer sequence 5′-3’Tm (°C)
siah2F:GCCCACAAGAGCATTACCAC59.80
R:GTTTCTCCAGCACCAGCAT57.60
NKX3.1F:GCCAAGAACCTCAAGCTCAC59.80
R:TTCTCCAAGTCTCCCAGCTC59.80
PMEPA1F:CTCCACCACACACACATCG59.70
R:CGCCTTCCTCTCACTCCTCT61.90
SLC45A3F:GAGCCGAGACGAAGCAGTT59.70
R:GCCAAAGGTTAGCAGGTTGA57.80
PSAF:TCCTCACAGCTGCCCACT60.58
R:ATATCGTAGAGCGGGTGTGG59.98
+ Open protocol
+ Expand
4

Quantitative RNA Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was separated from tissues and cells with the usage of TRIzol reagent (Invitrogen). RNA quality was examined by A260/A280 absorption. Briefly, cDNA was synthesized by using a TaqMan miRNA reverse transcription kit (Takara). The quantitative real-time PCR (RT-qPCR) was carried out with a SYBR Premix Ex Taq kit (TaKaRa) on an ABI 7500 RT-PCR system (Applied Biosystems, USA). Relative quantification was achieved by normalization to the amount of GAPDH mRNA or U6, and the relative expression levels of genes were calculated using 2–ΔΔCT method.
+ Open protocol
+ Expand
5

Quantifying LINC00641 and miR-582-5p Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using Trizol reagent (Takara, Japan). PrimeScriptTM RT Master Mix purchased from Takara and the Taqman miRNA reverse transcription Kit (Carlsbad, USA) were used for reverse-transcription. SYBR Select Master Mix was used for qPCR. The relative expression of LINC00641 and miR-582-5p were normalized to GAPDH and U6. The primers are as follows:
LINC00641:
Forward 5′-CAGCCTATGACAGACAGCCC-3′
Reverse 5′-CCAGTTGGTGCTGCCATTTG-3`
miR582-5p:
Forward 5′-ATCCCTAGCTTCAACGTG-3′
Reverse 5′-CGTTACAATTGCTAGC-3′
U6:
Forward 5′-CTCGCTTCGGCAGCACA-3′
Reverse5′-AACGCTTCACGAATTTGCGT-3′
GAPDH:
Forward 5′-ACAACTTTGGTATCGTGGAAGG-3′
Reverse 5′-GCCATCACGCCACAGTTTC-3′
+ Open protocol
+ Expand
6

Quantifying Liver and Cell MicroRNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA from livers and cells was isolated using the TRIzol reagent (TaKaRa, China) according to the manufacturer’s protocols, and reverse transcribed using a TaqMan miRNA Reverse Transcription Kit. The RNA was quantified using an Applied Biosystems 7300 System (Applied Biosystems, United States) using Quantitative RT-PCR (qPCR) with TaqMan miRNA assay Kit (GenePharma Corp, China). The quantity and purity of total RNA samples were tested by UV spectroscopy (Thermo Fisher Scientific, United States). The miRNA expression level was normalized to endogenous expression of RNA U6.
+ Open protocol
+ Expand
7

Evaluating Anti-miR21 Efficacy in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the efficiency of anti-miR21, MCF7 and MCF1/ADR (105 cells/well) cells were seeded in 12-well culture plates and incubated for 24 hours. The cells were then treated with HMNs containing anti-miR21 or scramble control at a final concentration of 213.3 nM for 48 hours.
Total RNA was extracted from cells with Trizol reagent (Thermo Fisher Scientific), and reverse-transcribed to complementary DNA using a TaqMan miRNA reverse-transcription kit (Takara, Kyoto, Japan). Then, real-time polymerase chain reaction (PCR) was performed on an Applied Biosystems 7500 (Thermo Fisher Scientific) using the TaqMan kit according to the standardized protocol. Both reverse transcription and PCR primers were purchased from GenePharma. miR21 expression was normalized using the
2ΔΔCT method relative to human U6 small nuclear RNA. All reactions were performed in triplicate. The change in miR21 expression was calculated as the fold variation relative to the untreated control.
+ Open protocol
+ Expand
8

Profiling of circ-SAR1A, miR-382, and YBX1 mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted through the RNeasy total RNA isolation kit (Invitrogen). cDNA was produced and amplified utilizing the TaqMan miRNA Reverse Transcription Kit (Takara, Dalian, China). circ-SAR1A, miR-382, and YBX1 mRNA were evaluated through qRT-PCR by TaqMan Human miRNA Assay Kit (Applied Biosystems) according to manufacturer’s recommendations. Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and U6 were employed as an endogenous reference. The data were assessed utilizing the 2–ΔΔCT method.
+ Open protocol
+ Expand
9

Plasma miR-497 Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma miR-497 was isolated by using miRNeasy Mini Kit (Qiagen, Valencia, CA). Reverse transcription was performed using the TaqMan miRNA reverse transcription kit (Takara, Japan). qRT-PCR was performed on ABI 7500 with SYBR Premix Ex Taq Kit (Takara, Japan). In short, the reactions were started at 95°C for 30s, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min. Internal control was the U6 small nuclear RNA. Ct value of samples was recorded. Data were normalized by using 2−ΔΔCt method [25 (link)].
+ Open protocol
+ Expand
10

Quantitative RT-PCR Analysis of Transcripts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol (Invitrogen) and reverse transcription was performed with PrimeScript RT reagent kit (Takara, Otsu, Japan) or TaqMan miRNA Reverse Transcription Kit (Takara) according to the manufacturer’s instructions. Quantitative RT-PCR was conducted using Power SYBR Green (TaKaRa) on StepOnePlus system (Applied Biosystems) with the following primer sequences: PRKAG2-AS1 forward: 5ʹ‐CCCAACTAGACACCTACATCC‐3ʹ and reverse: 5ʹ‐GCTTGATCTCTACCCTTGCTT‐3ʹ; SRRM2-AS1 forward: 5ʹ-TCCTGCTATCGCTTCCCAGT‐3ʹ and reverse: 5ʹ-GGTTGCGACGTAATAGGAAGGT‐3ʹ; STRADA, forward: 5′‐CGGGTGACACTCGGAGAAAA‐3′, reverse: 5′‐AGTGAGCAGCTCGTAACACC‐3; GAPDH forward: 5ʹ-GGAGCGAGATCCCTCCAAAAT‐3ʹ and reverse: 5ʹ‐GGCTGTTGTCATACTTCTCATGG‐3ʹ; miR‐6514, forward: 5′‐TATGGAGTGGACTTTCAGCTGGC‐3′, reverse: 5′‐CTGGAGTGGAAGAACAGGCA‐3′; miR‐1275, forward: 5′‐TGGGGGAGAGGCTGTC‐3′, reverse: 5′‐GAACATGTCTGCGTATCTC‐3′; U6, forward: 5′‐CTCGCTTCGGCAGCACAT‐3′, reverse: 5′‐TTTGCGTGTCATCCTTGCG‐3′; The relative expression level was calculated with 2−ΔΔCt method with GAPDH or U6 as the internal reference for normalization.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!